Advertisement

Topics

The Hartford Income Shares Fund, Inc. Company Profile

02:22 EDT 19th June 2018 | BioPortfolio

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to the fund’s future financial or business performance, strategies or expectations. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Forward-looking statements speak only as of the date they are made, and The Hartford assumes no duty to and does not undertake to update forward-looking statements. Actual results could differ materially from those anticipated in forward-looking statements and past performance is not an indication of future performance. We assume no obligation to update this release, which speaks as of the date issued.


News Articles [857 Associated News Articles listed on BioPortfolio]

Jeffrey Gundlach to Hold Fixed Income Allocation Webcast Today

The DoubleLine Core Fixed Income Fund (I shares: DBLFX; N shares DLFNX) is an intermediate-term bond fund. The DoubleLine Flexible Income Fund (I shares: DFLEX; Read more...

In Connecticut, Hartford Health is Ahead of the E-Prescribing Curve

Rajiv LeventhalConnecticut has joined just a handful of states that have passed electronic prescribing mandates. Hartford Health’s CMIO discusses the process in meeting the requirement and the resul...

RECORDATI: PRELIMINARY 2017 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITABILITY. SALES +11.6%, OPERATING INCOME +24.1%, NET INCOME +21.6%

Consolidated revenues € 1,288.1 million, +11.6%.EBITDA (1) € 454.7 million, +22.5%Operating income € 406.5 million, +24.1%.Net income € 288.8 million, +21.6%.Net financial position (2)...

SPDR S&P Biotech (Xbi) Shares Sold by Perkins Coie Trust Co

Perkins Coie Trust Co cut its position in SPDR S&P Biotech by 12.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission . The fund o...

Mylan (MYL) Holdings Raised by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D raised its position in shares of Mylan by 22.7% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission...

Bill Ackman Calls For Breakup Of United Technologies

HARTFORD (dpa-AFX) - Billionaire hedge-fund manager Bill Ackman called for a breakup of United Technologies Corp. (UTX) saying the individual businesses are more likely to trade at fair value as i...

RECORDATI: BOARD APPROVES THE 2017 ACCOUNTS. SALES € 1,288.1 MILLION (+11.6%), OPERATING INCOME € 406.5 MILLION (+24.1%) AND NET INCOME € 288.8 MILLION (+21.6%). 2017 DIVIDEND € 0.85 (+21.4%)

Consolidated revenues € 1,288.1 million, +11.6%. EBITDA (1) € 454.7 million, +22.5% Operating income € 406.5 million, +24.1%. Net income € 288.8 million, +21.6%. Net financial posi...

Tekla World Healthcare Fund Announces Renewal of Share Repurchase Program

Tekla World Healthcare Fund (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program ...

PubMed Articles [101 Associated PubMed Articles listed on BioPortfolio]

The role of the Technical Review Panel of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria: an analysis of grant recommendations.

The independent Technical Review Panel (TRP) of the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria is a unique mechanism to review funding proposals and to provide recommendations on their fu...

Stakeholder perspectives regarding transfer of free maternity services to National Health Insurance Fund in Kenya: Implications for universal health coverage.

Kenya is developing strategies to finance health care through prepayment to achieve universal health coverage (UHC). Plans to transfer free maternity services (FMS) from the Ministry of Health to the ...

Fires: fund research for citizen safety.

Does providing more services increase the primary hospitals' revenue? An assessment of national essential medicine policy based on 2,675 counties in China.

To understand whether the increased outpatient service provision (OSP) brings in enough additional income (excluding income from essential medicine) for primary hospitals (INCOME) to compensate for re...

Priorities for Peter Sands and the Global Fund.

Clinical Trials [69 Associated Clinical Trials listed on BioPortfolio]

Examine the Feasibility of a Standardized Field Test for Marijuana Impairment: Laboratory Evaluations

Marijuana is one of the most widely used substances. This study will characterize the persistence of cannabis' (CNB's) acute effects on cognitive test performance and simulated driving ove...

Stivarga Real Life Evidence in Hungary

The study aims to evaluate use of regorafenib in clinical practice in Hungary. The study should provide information about clinical characteristics of Hungarian regorafenib patients as well...

Effectiveness Study During the First 1,000 Days in Kenya

Malnutrition is a public health problem in Kenya, with 26% of children underfive years of age stunted, and 26% of pre-school children, 26% of women of reproductive age and 42% of pregnant ...

Enhanced Recovery After Surgery in Laparoscopic Sleeve Gastrectomy

While laparoscopic sleeve gastrectomy (LSG) has become the most commonly performed bariatric surgery procedure in the US and worldwide, it is associated with significant postoperative naus...

Cluster Randomized, Parallel-group, Prospective, Follow-up Effectiveness Study in Kenyan Children 6-35 Months

Malnutrition is a public health problem in Kenya, with 26% of children under-five years of age stunted, and 26% of pre-school children, 26% of women of reproductive age and 42% of pregnant...

Companies [680 Associated Companies listed on BioPortfolio]

The Hartford Income Shares Fund, Inc.

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act, with respect to the fund’s future financial or b...

BioPharma Fund

BioPharma Fund is an investment fund that invests in shares of medical biotechnology companies. Biotechnology companies are developing new drugs for many diseases such as cancer, heart disease, diabet...

The Hartford Financial Services Group, Inc.

Celebrating 200 years of helping its customers achieve what's ahead, The Hartford (NYSE: HIG) is an insurance and wealth management company. Through its unique focus on customer n...

The Hartford

The Hartford is one of the few companies in the United States with in-house experts on aging. For over 25 years, The Hartford has employed gerontologists to advance the creation a...

The Hartford Financial Services Group Inc.

The Hartford Financial Services Group Inc. (NYSE: HIG) is a leading provider of insurance and wealth management services for millions of consumers and businesses worldwide. A Fort...

More Information about "The Hartford Income Shares Fund, Inc." on BioPortfolio

We have published hundreds of The Hartford Income Shares Fund, Inc. news stories on BioPortfolio along with dozens of The Hartford Income Shares Fund, Inc. Clinical Trials and PubMed Articles about The Hartford Income Shares Fund, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Hartford Income Shares Fund, Inc. Companies in our database. You can also find out about relevant The Hartford Income Shares Fund, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record